Diana Roettger, PhD, and Olga Kubassova, PhD[email protected]MRIAdvanced imaging offers insight into targeted therapiesMajor breakthroughs are emerging in the development of targeted therapies that use the body's own immune system to attack cancer cells. But traditional methods of measuring the success of drug candidates are slow and expensive. Could advanced imaging help? Diana Roettger, PhD, and Olga Kubassova, PhD, of the Image Analysis Group offer a perspective.February 5, 2019Page 1 of 1Top StoriesRisk ManagementAudit in Canada finds higher after-hours payments for teleradiology didn't qualifyAfter-hours premium payments for publicly funded teleradiology reads did not meet all the criteria outlined in the agreements.InterventionalAI supports remote guidance of IR proceduresCTThoracic radiologists publish post-COVID CT imaging recommendationsInterventionalGAE further validated for patients with knee osteoarthritisSponsor ContentWhen time is of the essence
